Under Metastatic Cancer section from European Urology published on 2016 Invasive bladder cancer is associated with a high mortality rate. Hence, the European Association of Urology (EAU) releases updated guidelines every year to optimize diagnosis, treatment, and follow-up in patients with Muscle-invasive and Metastatic Bladder Cancer (MIBC). What Is This Guideline About?
The guideline provides recommendations regarding diagnostic pathways and treatment options in patients with Muscle-invasive and Metastatic Bladder Cancer (MIBC). The guideline includes: Potential indications and contraindications, such as comorbidity related to treatment choice A new paragraph on organ-sparing approaches and on minimal invasive surgery Recommendations for chemotherapy with, second-line options Follow-up schedules What Was Need For Guideline? Bladder cancer is the most commonly diagnosed cancer…
